INMD (NASDAQ) - InMode Ltd

Exchange: USA Stocks • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0011595993
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for INMD (NASDAQ) - InMode Ltd


Market Cap in USD 3,287m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2019-08-08


Fundamental 4.33
Dividend -
Performance 5y 5.79
Rel. Performance vs Sector -0.22
Analysts 4.50
Fair Price Total Ret. 30.84
Fair Price DCF todo


Growth TTM 6.21%
CAGR 5y 43.69%
CAGR / Mean Drawdown 5y 1.12
Sharpe Ratio TTM 0.02
Alpha vs SP500 TTM -33.32
Beta vs SP500 5y weekly 2.01
CAPM 9.62%
Average Daily Range 2m 3.13%
Reversal Oscillator 4.72
Volatility GJR Garch 1y 44.56%
Price / SMA 50 -20.9%
Price / SMA 200 -15.74%
Current Volume 2109.8k
Average Volume 20d 1212.6k


Yield TTM 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Consistency of Dividends all time 0.0%